Cost of treatment of metastatic non-small lung cancer in Sweden, 2011-2023
{{output}}
Background and purpose: Metastatic non-small cell lung cancer (mNSCLC) contributes to the economic burden. Over the past decade, treatment has evolved with the introduction of epidermal growth factor receptor (EGFR) anaplastic ly... ...
